QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in
OTCMKTS:ALPMY

Astellas Pharma Short Interest Ratio and Short Volume

$16.83
+0.01 (+0.06 %)
(As of 02/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.70
Now: $16.83
$16.85
50-Day Range
$15.27
MA: $16.44
$17.41
52-Week Range
$12.48
Now: $16.83
$18.43
Volume59,157 shs
Average Volume84,402 shs
Market Capitalization$31.33 billion
P/E Ratio24.39
Dividend Yield1.72%
Beta0.63

Short Interest

Astellas Pharma (OTCMKTS:ALPMY) Short Interest Data

Current Short Volume:11,500 shares
Previous Short Volume:78,400 shares
Change Vs. Previous Month:-85.33%
Dollar Volume Sold Short:$188,370.00
Short Interest Ratio / Days to Cover:0.0
Last Record Date:January, 29 2021
Outstanding Shares:1,861,790,000 shares
Percentage of Shares Shorted:0.00%
Today's Trading Volume:59,157 shares
Average Trading Volume:84,402 shares
Today's Volume Vs. Average:-29.91%


Astellas Pharma (OTCMKTS:ALPMY) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/29/202111,500 shares $188,370.00 -85.3%N/A0.1 $16.38
1/15/202140,400 shares $642,764.00 -34.0%N/A0.2 $15.91
12/31/202040,400 shares $622,160.00 -34.0%N/A0.2 $15.40
12/15/202040,400 shares $589,436.00 -34.0%N/A0.2 $14.59
11/30/202061,200 shares $905,760.00 +367.2%N/A0.5 $14.80
11/15/202013,100 shares $187,330.00 +718.8%N/A0.1 $14.30
10/30/20201,600 shares $24,832.00 -88.8%N/A0 $15.52
10/15/202014,300 shares $196,911.00 +44.4%N/A0.1 $13.77
9/30/20209,900 shares $140,877.00 +125.0%N/A0.1 $14.23
9/15/20204,400 shares $67,364.00 -91.3%N/A0 $15.31
8/31/202050,800 shares $796,036.00 +681.5%N/A0.4 $15.67
8/14/20206,500 shares $102,180.00 -59.4%N/A0.1 $15.72
7/31/202016,000 shares $264,640.00 +742.1%N/A0.1 $16.54
7/15/20201,900 shares $29,830.00 -96.6%N/A0 $15.70
6/30/202056,000 shares $893,200.00 +266.0%N/A0.6 $15.95
6/15/202015,300 shares $247,860.00 +393.6%N/A0.1 $16.20
5/29/20203,100 shares $52,018.00 -35.4%N/A0 $16.78
5/15/20204,800 shares $85,632.00 -66.0%N/A0.1 $17.84
4/30/202014,100 shares $237,867.00 +65.9%N/A0.1 $16.87
4/15/20208,500 shares $142,460.00 +7.6%N/A0.1 $16.76
3/31/20207,900 shares $129,165.00 -92.7%N/A0 $16.35
3/13/2020107,900 shares $1.67 million +233.0%N/A0.7 $15.52
2/28/202032,400 shares $427,032.00 -20.6%N/A0.4 $13.18
2/14/202040,800 shares $641,376.00 +164.9%N/A0.5 $15.72
1/31/202015,400 shares $249,172.00 -32.5%N/A0.3 $16.18

Astellas Pharma (OTCMKTS:ALPMY) Short Interest FAQ

speech bubbles
speech bubbles











What is Astellas Pharma's current short interest?

Short interest is the volume of Astellas Pharma shares that have been sold short but have not yet been closed out or covered. As of January 29th, traders have sold 11,500 shares of ALPMY short.

Is Astellas Pharma's short interest increasing or decreasing?

Astellas Pharma saw a decrease in short interest in January. As of January 29th, there was short interest totaling 11,500 shares, a decrease of 85.3% from the previous total of 78,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Astellas Pharma's short interest compare to its competitors?

0.00% of Astellas Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Astellas Pharma: Sanofi (0.00%), CSL Limited (0.00%), GlaxoSmithKline plc (0.00%), Zoetis Inc. (0.78%), Bayer Aktiengesellschaft (0.00%), Vertex Pharmaceuticals Incorporated (0.00%), Takeda Pharmaceutical Company Limited (0.20%), Regeneron Pharmaceuticals, Inc. (1.90%), Alexion Pharmaceuticals, Inc. (2.00%), and Shiseido Company, Limited (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon Plc ($5.34 billion), Charter Communications, Inc. ($5.03 billion), ViacomCBS Inc. ($4.99 billion), DuPont de Nemours, Inc. ($4.72 billion), Analog Devices, Inc. ($4.57 billion), Snap Inc. ($3.87 billion), Moderna, Inc. ($3.58 billion), Futu Holdings Limited ($2.75 billion), Snowflake Inc. ($2.43 billion), and Palantir Technologies Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Astellas Pharma stock?

Short selling ALPMY is an investing strategy that aims to generate trading profit from Astellas Pharma as its price is falling. Astellas Pharma's stock is trading up $0.01 today. To short Astellas Pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Astellas Pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Astellas Pharma?

A short squeeze for Astellas Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPMY, which in turn drives the price of the stock up even further.

How often is Astellas Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPMY, twice per month. The most recent reporting period available is January, 29 2021.



This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.